U.S. Launch of a Ex-U.S. Oncology Agent

Market Access

Prepared a small biotechnology company for the U.S. launch of a new oral oncology agent by supporting the commercial team’s focus on challenges associated with U.S. commercial entrance of an ex-U.S. company.

Prepared a small biotechnology company for the U.S. launch of a new oral oncology agent by supporting the commercial team’s focus on challenges associated with U.S. commercial entrance of an ex-U.S. company, providing payer management strategies under the medical vs the pharmacy benefit, and using pathways and other UM tools – prior authorization, tiering, and current and future impact of pricing strategy on access.

Reach out

Own your edge

We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.

Start now.